NFKB1 and colitis: Using an IBD-PSC mouse model, we define a protective circuit by which colitis alleviates liver impairment and fibrosis of murine sclerosing cholangitis, a process mediated by suppression of BA metabolism via hepatic inflammatory signaling and more specifically NF-κB activation.